Published on GHDx (https://ghdx.healthdata.org)

Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study

General Info

Geography 
United States of America (USA)
Connecticut
Time period covered 
January, 2020 - December, 2020
Data type
Scientific literature
Keywords 
COVID-19

Citation

Authors 
Mahajan S, Srinivasan R, Redlich CA, Huston SK, Anastasio KM, Cashman L, Massey DS, Dugan A, Witters D, Marlar J, Li SX, Lin Z, Hodge D, Chattopadhyay M, Adams MD, Lee C, Rao LV, Stewart C, Kuppusamy K, Ko AI, Krumholz HM
Journal 
Am J Med
Pages 
526-534e11
Publication year 
2021
Suggested citation 
Mahajan S, Srinivasan R, Redlich CA, Huston SK, Anastasio KM, Cashman L, Massey DS, Dugan A, Witters D, Marlar J, Li SX, Lin Z, Hodge D, Chattopadhyay M, Adams MD, Lee C, Rao LV, Stewart C, Kuppusamy K, Ko AI, Krumholz HM. Seroprevalence of SARS-CoV-2-Specific IgG Antibodies Among Adults Living in Connecticut: Post-Infection Prevalence (PIP) Study. Am J Med. 2021; 134(4): 526-534e11.
Source URL:https://ghdx.healthdata.org/record/seroprevalence-sars-cov-2-specific-igg-antibodies-among-adults-living-connecticut-post-0#comment-0